(919) 224-8800 Contact Our Team

Free eBook:

Cancer Drug Development Using Molecular Pathology

Most oncology drugs are currently prescribed based on histology and not molecular profile. As a result, it is estimated only 25% of patients with any given histologically defined cancer will benefit from any given drug.

Molecular-based, personalized cancer therapy enables treatment decisions based on tumor molecular profile rather than traditional histology, resulting in more accurate diagnosis, prognosis and reduced toxicity, leading to improved clinical outcomes such as treatment response and survival.

In this eBook, we review:

  • The history of cancer diagnosis and treatment  
  • The use of molecular profiling in drug development 
  • An overview of enabling technologies 
  • Regulatory considerations 
  • The future of molecular profiling in cancer therapies

Download the eBook now: